A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors
Clinical trial NCT05764915 · TERMINATED
Trial details
- NCT number
- NCT05764915
- Sponsor
- Regor Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2024-02-20
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.